Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 for Deep Sleep Optimization: Comparison

MK-677 Ghrelin receptor agonist. Amplifies endogenous GH pulses Increases Stage 4 sleep by 50%, reduces REM latency, improves sleep continuity None. Does not suppress natural GH production Best for sleep architecture optimization; requires consistent timing an

This comparison does not assign a generated winner or score.

  • MK-677
  • Ghrelin receptor agonist. Amplifies endogenous GH pulses
  • Increases Stage 4 sleep by 50%, reduces REM latency, improves sleep continuity
  • None. Does not suppress natural GH production
  • Best for sleep architecture optimization; requires consistent timing and appetite management
  • Melatonin
  • Pineal hormone. Regulates circadian rhythm signaling
  • Reduces sleep onset latency by 7–10 minutes; minimal effect on deep sleep stages
  • Low. May desensitize melatonin receptors with long-term use
  • Effective for circadian misalignment (jet lag, shift work); does not deepen sleep architecture
  • Magnesium Glycinate
  • NMDA receptor antagonist. Modulates GABA activity
  • Reduces time to fall asleep; mild anxiolytic effect; no measurable effect on slow-wave sleep
  • None
  • Useful for anxiety-driven insomnia; does not address sleep architecture deficits
  • Benzodiazepines
  • GABA-A receptor positive allosteric modulator
  • Increases total sleep time but suppresses REM and Stage 4 sleep
  • High. Tolerance develops within 2–4 weeks
  • Contraindicated for long-term use; impairs restorative sleep quality despite sedation
More references

Related material